Related Experiment Videos
Weak magnetic fields as a novel therapeutic modality in Parkinson's disease
The International Journal of Neuroscience
|September 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Resolution of partial cataplexy in multiple sclerosis by treatment with weak electromagnetic fields.
The International journal of neuroscience·1996
Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields.
The International journal of neuroscience·1995
Improvement of body image perception in Parkinson's disease by treatment with weak electromagnetic fields.
The International journal of neuroscience·1995
Reversal of visuospatial deficit on the Clock Drawing Test in Parkinson's disease by treatment with weak electromagnetic fields.
The International journal of neuroscience·1995
Weak electromagnetic fields improve body image perception in patients with multiple sclerosis.
The International journal of neuroscience·1995
Weak electromagnetic fields restore dream recall in patients with multiple sclerosis.
The International journal of neuroscience·1995
Aquaporin-4 mediated glymphatic dysfunction and neuroinflammatory signaling in neurodegenerative disorders.
The International journal of neuroscience·2026
Combined assessment of established biomarkers: monocyte-to-HDL ratio and carotid IMT in association with acute ischemic stroke.
The International journal of neuroscience·2026
miR-4508 targets PLCB2 in propofol-induced neurotoxicity in sH-SY5Y cells: role and mechanism.
The International journal of neuroscience·2026
Diagnostic value of miR-34c-5p in acute cerebral infarction and its correlation with prognostic outcomes of rehabilitation.
The International journal of neuroscience·2026
Polycation chain length determines the in vivo mRNA delivery efficiency of block copolymer micelles.
Biomaterials science·2026
Driving Drugs Deeper: Force-Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation.
Small (Weinheim an der Bergstrasse, Germany)·2026
Mumio Potentiates Temozolomide by Inducing Apoptosis and Ferroptosis in Glioblastoma Cells.
Current pharmaceutical design·2026
Current Targeted Nanoparticle Therapy for Alzheimer's Disease: Current Advances and Future Prospects.
Current neurovascular research·2026
Clinical Presentation, Diagnosis, Treatment, and Outcome of Heart Disease in Becker Muscular Dystrophy.
Anatolian journal of cardiology·2026
Clinical Pharmacology of Eplontersen, the First Approved GalNAc-Conjugated Antisense Oligonucleotide.
Journal of clinical pharmacology·2026